Order Article Reprints

Jiménez N, Reig Ò, Marín-Aguilera M, Aversa C, Ferrer-Mileo L, Font A, Rodriguez-Vida A, Climent MÁ, Cros S, Chirivella I, et al. Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel. Cancers. 2022; 14(19):4757. https://doi.org/10.3390/cancers14194757

Jiménez, Natalia, Òscar Reig, Mercedes Marín-Aguilera, Caterina Aversa, Laura Ferrer-Mileo, Albert Font, Alejo Rodriguez-Vida, Miguel Ángel Climent, Sara Cros, Isabel Chirivella, and et al. 2022. "Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel" Cancers 14, no. 19: 4757. https://doi.org/10.3390/cancers14194757

Jiménez, N., Reig, Ò., Marín-Aguilera, M., Aversa, C., Ferrer-Mileo, L., Font, A., Rodriguez-Vida, A., Climent, M. Á., Cros, S., Chirivella, I., Domenech, M., Figols, M., González-Billalabeitia, E., Jiménez Peralta, D., Rodríguez-Carunchio, L., García-Esteve, S., Garcia de Herreros, M., Ribal, M. J., Prat, A., & Mellado, B. (2022). Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel. Cancers, 14(19), 4757. https://doi.org/10.3390/cancers14194757